The Otology Section also is recognized for excellence in clinical and basic science research in adult sensorineural hearing loss (SHL). Dr. Hughes is Cleveland Clinic's principal investigator in a NIH-funded, five-year, multicenter study of intratympanic steroid treatment for sudden SHL. In autoimmune SHL, Dr. Hughes is co-investigator in an NIH grant submitted March 1st by Vincent Tuohy PhD of the Lerner Research Institute.
Research Fellow Hyun-Min Park MD from Seoul, Korea assists Dr. Tuohy in the laboratory this year. Dr. Tuohy’s and Dr. Hughes’ combined work exemplifies the type of translational research encouraged by Cleveland Clinic.